TAM Receptor Inhibitors

Axl

Mer

Tyro3

TAM Receptor Inhibitors

Product Name	Axl	Mer	Tyro3	Purity
Bemcentinib	Axl			99.92%
Cabozantinib	Axl			99.97%
Gilteritinib	Axl			99.84%
2-D08	Axl			99.37%
BMS 777607	Axl		Tyro3	99.36%
Ladarutatug	Axl
TAM-IN-1	Axl, Ki: 130 pM	Mer, Ki: <50 pM
UNC2250	Axl	Mer		99.92%
Zanzalintinib	Axl	Mer		99.91%
LDC1267	Axl, IC₅₀: 42 nM	MERTK, IC₅₀: 130 nM	Tyro3, IC₅₀: 63 nM	99.64%
Dubermatinib	Axl			99.84%
UNC569	Axl	Mer	Tyro3	99.92%
UNC5293	Axl		Tyro3	99.93%
Gilteritinib hemifumarate	Axl			99.75%
UNC2541		Mer		99.71%
Tamnorzatinib	Axl	Mer	Tyro3	98.59%
Batiraxcept	Axl			99.91%
CEP-40783	Axl			99.61%
SGI-7079	Axl			99.32%
Tilvestamab	Axl			98.08%
UNC1062	Axl, : 85 nM		Tyro3, : 60 nM	98.92%
NPS-1034	Axl			98.0%
UNC9426	Axl, IC₅₀: 190 nM	MERTK, IC₅₀: 580 nM	Tyro3, IC₅₀: 2.1 nM	99.51%
RU-302	Axl			98.72%
UNC2881	Axl	Mer		99.79%
Enapotamab	Axl			99.9%
Ningetinib	Axl			99.82%
Mecbotamab	Axl			99.83%
PF-07265807	Axl, IC₅₀: 0.9 nM	Mer, IC₅₀: 2.3 nM	Tyro3, IC₅₀: 6 nM
Adrixetinib	Axl, Kd: 0.3 nM	Mer, Kd: 0.8 nM		99.55%
UNC4203	Axl		Tyro3	99.80%
AZ14145845	Axl	Mer		98.00%
DS-1205b free base	Axl	Mer		99.92%
PROTAC Axl Degrader 2	Axl			98.01%
Cabozantinib-d₆	Axl			98.14%
AXL-IN-13	Axl			98.03%
Ningetinib Tosylate	Axl			99.59%
Adrixetinib TFA	Axl, Kd: 0.3 nM	Mer, Kd: 0.8 nM		99.82%
Mipasetamab	Axl			98.26%
TL4830031	Axl			≥98.0%
AG01	Axl
Cabozantinib hydrochloride	Axl
Axl-IN-6	Axl
UNC8212	Axl, IC₅₀: 1.3 nM	MERTK, IC₅₀: 1.5 nM	Tyro3, IC₅₀: 6.7 nM
Axl-IN-9	Axl
Axl-IN-11	Axl
PROTAC Axl Degrader 1	Axl
Axl-IN-4	Axl
Axl-IN-17	Axl, IC₅₀: 3.23 nM	Mer	Tyro3
Axl-IN-10	Axl
Bemcentinib (GMP)	Axl
HIV-IN-7	Axl
Axl/Mer/CSF1R-IN-1	Axl	Mer
Axl-IN-21	Axl, IC₅₀: 4 nM Axl, Kd: 2.7 nM	Mer, Kd: 1.4 nM
UNC3133	Axl, IC₅₀: 17 nM	MERTK, IC₅₀: 3.0 nM	Tyro3, IC₅₀: 31 nM
Axl-IN-12	Axl
AXL-IN-15	Axl
Axl-IN-7	Axl
NTQ2494	Axl, IC₅₀: 4.89 nM
Axl-IN-19	Axl, IC₅₀: 5.3 nM
Axl-IN-16	Axl
Axl-IN-8	Axl
Anticancer agent 109	Axl
Axl-IN-3	Axl
R916562	Axl
AXL-IN-14	Axl
Axl-IN-5	Axl

Name
Email *

	Sorry, but the email address you supplied was invalid.